Pharmacy News EU

FLORHAM PARK, N.J., July 29 /PRNewswire/ Shionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. Food and Drug Administration approval of CUVPOSA? (glycopyrrolate), the first liquid treatment for patients ages 3-16 who suffer from chronic severe drooling associated with neurologic conditions such as cerebral palsy. CUVPOSA? was designated [...]

MONMOUTH JUNCTION, N.J., July 28 /PRNewswire/ Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced that the US Food and Drug Administration (FDA) has approved a first-time generic of Methylphenidate Hydrochloride Oral Solution equivalent to brand name Methylin Oral Solution marketed by Shionogi Pharmaceuticals, Inc."Tris pursues selective generic opportunities, especially [...]

MADISON, N.J., July 28 /PRNewswire/ An accurate, faster testing option to identify female carriers and other patients with genetic abnormalities that cause Fragile X Syndrome is now available to physicians in all fifty states with the recent approval in New York. Fragile X is the leading cause of inherited mental retardation and the most [...]

- Company on Target to File NDA in 2010 – EWING, N.J.(BUSINESS WIRE) Antares Pharma, Inc. (NYSE Amex:AIS) announced today positive results from its Phase 3 study of AnturolTM Gel in patients with [...]

Current study results from the report, ‘Realizing patient-centered care: putting patients in the center, not the middle,’ have been published. "In these challenging times, healthcare executives must make difficult decisions when setting goals and allocating resources within their organizations. Patient-centered care means putting the patient in the center, not in the middle," researchers in the [...]

WAYNE, N.J., July 26 /PRNewswire/ MAQUET Cardiovascular today announced the launch of its VASOVIEW HEMOPRO 2 Endoscopic Vessel Harvesting (EVH) System, which utilizes next-generation HEMOPRO cut-and-seal technology to reduce thermal spread and to achieve optimal conduit quality for coronary artery bypass graft (CABG) surgery patients. The minimally invasive VASOVIEW HEMOPRO 2 system is an [...]

BOONTON, N.J.(BUSINESS WIRE) Unigene Laboratories, Inc. (OTCBB: UGNE, http://www.unigene.com) today noted that Tarsa Therapeutics has completed patient enrollment in the Phase III ORACAL trial of Tarsa’s oral calcitonin product for the treatment of postmenopausal osteoporosis. [...]

BOONTON, N.J.(BUSINESS WIRE) Unigene Laboratories, Inc. (OTCBB: UGNE, http://www.unigene.com) announced today that Novartis and its license partner Nordic Bioscience [the Sponsor?] have decided to continue the companies two-year, Phase III Study 2302 assessing safety and [...]

State’s oldest and largest health insurer to create a new company to energize transformation of health care in New Jersey NEWARK, N.J.(BUSINESS WIRE) Most health care experts agree that, despite federal health care reform, [...]

Rochester NY www.shamrockstocks.com names (OTCBB:ORNI) Oragenics, Inc., (OTCBB:UGNE) Unigene Laboratories, Inc., and (OTCBB:VIVK) Vivakor Inc. it’s "Lucky Picks of the Day!To feature your publicly traded company in our alers email us at info@shamrockstocks.com.Also, you can receive up to the minute stock alerts via our Twitter page. www.twitter.com/shamrockstocks
Visit: www.shamrockstocks.comAbout Oragenics, IncOragenics, Inc. biopharmaceutical company is [...]